Bayer Statement on Solicitor General’s Amicus Brief in the Hardeman Appeal
Bayer Statement on Solicitor General's Amicus Brief in the Hardeman Appeal
Farmers and growers have been using glyphosate-based herbicides safely and effectively to control weeds for more than 40 years. These products continue to play a critical role in helping farmers manage weeds and sustainably deliver crops to markets around the world.
The litigation over glyphosate primarily stems from one place: an opinion by a group called IARC. IARC is not a regulatory authority and did not conduct any original scientific studies. Yet in 2015, after IARC classified glyphosate as a “probable carcinogen,” trial attorneys in the U.S. began running advertisements to recruit plaintiffs for lawsuits against Monsanto, the manufacturer of many glyphosate-based herbicides (i.e., RoundupTM-branded herbicides). These lawsuits rely heavily on IARC’s classification, which has many significant limitations and flaws and runs counter to an extensive body of science supporting glyphosate’s safe use. More than four years after reaching its opinion, leading pesticide regulators around the world continue to conclude that glyphosate is not carcinogenic and that glyphosate-based herbicides are safe when used as directed.
Bayer will vigorously defend its products based on the strong body of science that confirms glyphosate and glyphosate-based products are safe when used as directed and that glyphosate does not cause cancer.
On December 9, 2021 the jury reached a verdict in favor of Monsanto in the Stephens trial in the Superior Court of California, County of San Bernardino.
Read here for Bayer's statement.
On October 5, 2021 the jury reached a verdict in favor of Monsanto in the Clark trial in the Superior Court of California, County of Los Angeles.
Read here for Bayer's statement.
On May 14, 2021, the Ninth Circuit Court of Appeals upheld the judgment in Hardeman. On August 16, 2021, Bayer – through its subsidiary Monsanto – filed its Petition for a Writ of Certiorari with the U.S. Supreme Court asking them to review the case. On May 10, 2022, the Solicitor General filed an amicus brief in the appeal.
On December 13, 2021, the Supreme Court called for the Views of the Solicitor General as they review the Company's petition. Read Bayer's statement here.
Key Dates
On March 17, 2022 Monsanto filed a petition for certiorari with the U.S. Supreme Court in its appeal of the Pilliod verdict. Read Bayer's statement here.
Key Dates
Monsanto filed to appeal the Johnson verdict in the Court of Appeal of the State of California and believes that the liability verdict and damage awards are not supported by the evidence at trial or the law. On March 19, 2021, Bayer announced that it had decided not to file a petition for certiorari with the U.S. Supreme Court, which will bring an end to the case. The decision was not based on the merits of this case but reflects strategic considerations that the Hardeman case, currently pending in the United States Court of Appeals for the Ninth Circuit, will serve as a better case for review by the Supreme Court.
Key Dates
Bayer Statement on Solicitor General's Amicus Brief in the Hardeman Appeal
The Washington Legal Foundation filed an amicus brief in support of Monsanto's petition to the Supre...
Today Monsanto filed a petition for certiorari with the U.S. Supreme Court in its appeal of the Pill...